Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Specific B-cell Memory After a Single Dose or Booster MenC Conjugate Vaccination in Adults
2006-002358-31Phase 4Completed
- Sponsor
- National Institute for Public Health and the Environment
- Start
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Meningococcal group C polysaccharide conjugate vaccine in Serogroup C meningococcal disease (MenC) (2 arms), sponsored by National Institute for Public Health and the Environment. Started May 2006; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccine
03
Conditions
Serogroup C meningococcal disease (MenC)
Beyond the preview
Go deeper on 2006-002358-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002358-31.